Cipla buys 60% stake in Sri Lankan co for $14m

Tags: Companies
Pharmaceutical firm Cipla Ltd today said it has acquired 60 per cent stake in a new company in Sri Lanka for $14 million (nearly Rs 85 crore) to market its product in the country.

Cipla (Mauritius) Ltd, a wholly owned subsidiary of the Indian company, has signed a definitive agreement with its existing Sri Lankan distributor for acquisition of 60 per cent stake in a new company, Cipla said in a filing to the BSE.

The new company will market the Cipla's products in Sri Lanka, it added.

"The consideration payable for the transaction is $14 million," the filing said, adding that the proposed acquisition was subject to regulatory approvals.

As part of its global expansion, Cipla has been active in acquisitions.

Last year, it completed the buyout of South African pharma firm Cipla Medpro for Rs 2,707 crore.

Cipla had also acquired Croatia-based firm Celeris, distributor of its products in that country last December.

Shares of Cipla were trading at Rs 411.30 per scrip in the afternoon trade, down 0.56 per cent from the previous close on the BSE.

EDITORIAL OF THE DAY

  • School exams need a overhaul under the direct supervision of the HRD ministry

    Theatre Of The Absurd. Bihar students need not be ashamed of mass cheating in exams.

FC NEWSLETTER

Stay informed on our latest news!

TODAY'S COLUMNS

Sandeep Bamzai

Disequilibrium: BLOOD, GORE & GUTS

The battle to control India's coal capital - Dhanbad - ...

Ananda Majumdar

<b>Ruminations:</b> WALKING ON A THIN EDGE

A social media post doing the rounds says, with some ...

Zehra Naqvi

Creativity springs from being open to experimentation

When Albert Einstein published his first revolutionary paper on the ...